<DOC>
	<DOCNO>NCT00890123</DOCNO>
	<brief_summary>The perioperative administration n-3 fatty acid show lead favorable effect outcome patient severe surgical intervention lower magnitude inflammatory response modulate immune response . No study preoperative administration IV omega 3 fatty acid part total parenteral nutrition ( TPN ) monotherapy demonstrate effect inflammatory immune response conduct . So , study plan judge inflammatory response preoperative monotherapy IV omega 3 fatty acid elderly patient undergo hip surgery consider hyper-inflammation associate type surgery elderly patient .</brief_summary>
	<brief_title>Preoperative Intravenous Omega 3 Fatty Acids Administration Elderly Patients Undergoing Hip Surgery</brief_title>
	<detailed_description />
	<criteria>1 . Elderly male female patient undergo hip surgery 2 . Age &gt; 60 year 3 . The patient give write informed consent 1 . Refusal participate study 2 . Allergy constituent nutritional product 3 . HIV positive patient , patient primary diagnosis hypertriglyceridemia , patient long term steroid therapy cyclooxygenase inhibitor ( 3 month ) 4 . Severe cardiac disease , hepatic disorder ( total bilirubin &gt; 1.5 time upper limit normal ) , psychiatric disorder likely affect compliance , severe hemorrhagic disorder , stroke , embolism 5 . Uncontrolled severe renal failure ( Serum creatinine &gt; 2 mg/dL ) without dialysis/hemofiltration 6 . Participation clinical trial within last 2 month</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Omega 3 Fatty Acids</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Hip Surgery</keyword>
	<keyword>Inflammatory status</keyword>
	<keyword>Infectious complication</keyword>
</DOC>